Validating a Novel Digital Face-Name Platform for Memory Enhancement in the Cognitively Healthy: A Baseline for Mild Cognitive Impairment Application
DOI:
https://doi.org/10.58445/rars.2095Keywords:
Mild Cognitive Impairment, Cognitive Training, Face-Name Paradigm, Associative Memory, Memory Enhancement, NeuroplasticityAbstract
Mild Cognitive Impairment is a transitional stage for more severe conditions like Dementia and Alzheimer’s disease, and previous research has shown that memory training exercises have shown promise in mitigating symptoms. We hypothesize that the use of a digital platform for repetitive face-name pair recall– FNAME-CogniFuse–will significantly improve memory retention in cognitively healthy individuals.The platform’s training model involved three key stages: an Encoding phase where participants learned face-name pairs, a 15-minute Break phase for memory consolidation, and a three-part Recall phase to test associative memory, free recall, and confidence ratings. A structured training program using FNAME-CogniFuse was conducted with 24 participants under 18. The results demonstrated an average of 34% overall increase in memory recall accuracy (p-value of .0017) from the primary to the final session. In associative memory, we observed a 36% improvement (p = 0.0014). Free recall accuracy showed an 11% decline, which was not significant. Answer confidence increased by 48% (p = 0.003). Notably, demographic analysis revealed a 59.63% average increase in memory scores for White participants and a 23.79% average increase for Asian participants, though this difference was not significant. The results revealed that the platform effectively enhances associative memory and answer confidence, suggesting its potential as an accessible cognitive training tool. Therefore, the FNAME-CogniFuse platform has significant potential as both an at-home cognitive training tool for healthy individuals and, with further validation, a clinical tool for MCI patients.
References
Alzheimer’s Disease International. (2019). World Alzheimer Report 2019: Attitudes to dementia. https://www.alzint.org/u/WorldAlzheimerReport2019.pdf
Belleville, S. (2008). Cognitive training for persons with mild cognitive impairment. International Psychogeriatrics / IPA, 20(1). https://doi.org/10.1017/S104161020700631X
Campbell, M. (2019). The meaning and history of first names - behind the name. Behindthename.com. https://www.behindthename.com
Cepeda, N. J., Pashler, H., Vul, E., Wixted, J. T., & Midzak, M. (2006). Spacing effects in learning: A temporal ridgeline in the role of memory. Psychological Science, 17(6), 451-455. https://doi.org/10.1111/j.1467-9280.2006.01737.x
Choi, J., Lee, J., & Lee, K. (2017). Effects of name familiarity on face-name associative memory. Frontiers in Psychology, 8, Article 1263. https://doi.org/10.3389/fpsyg.2017.01263
Craik, F. I. M., & Lockhart, R. S. (1972). Levels of processing: A framework for memory research. Journal of Verbal Learning and Verbal Behavior, 11(6), 671–684. https://doi.org/10.1016/S0022-5371(72)80001-X
De Felice, F. G., & Ferreira, S. T. (2014). Involvement of neuroinflammation in Alzheimer's disease pathophysiology. Frontiers in Neuroscience, 8, 1-7. https://doi.org/10.3389/fnins.2014.0000
Eichenbaum, H. (2017). Where are you going? The neurobiology of navigation: The role of the hippocampus in navigation is memory. Journal of Neurophysiology, 117(4), 1785.
Ferrara, E. (2023). Fairness and bias in artificial intelligence: A brief survey of sources, impacts, and mitigation strategies. Sci, 6(1), 3. https://doi.org/10.3390/sci6010003
Golde, T. E. (2022). Disease-modifying therapies for Alzheimer’s disease: More questions than answers. Neurotherapeutics: The Journal of the American Society for Experimental Neurotherapeutics, 19(1), 209.
Jaeggi, S. M., Buschkuehl, M., Jonides, J., & Perrig, W. J. (2008). Improving fluid intelligence with training on working memory. Proceedings of the National Academy of Sciences, 105(19), 6829–6833. https://doi.org/10.1073/pnas.0801268105
Koch, M., & Laskowski, M. (2017). Neuroplasticity and Alzheimer's disease. Frontiers in Aging Neuroscience, 9, 190. https://doi.org/10.3389/fnagi.2017.00190
Hampstead, B. M., Sathian, K., Moore, A. B., Nalisnick, C., & Stringer, A. Y. (2008). Explicit memory training leads to improved memory for face-name pairs in patients with mild cognitive impairment: Results of a pilot investigation. Journal of the International Neuropsychological Society, 14(5), 883–889.
Langa, K. M., & Levine, D. A. (2014). The diagnosis and management of mild cognitive impairment: A clinical review. JAMA: The Journal of the American Medical Association, 312(23), 2551–2561.
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., Costafreda, S. G., Dias, A., Fox, N., Gitlin, L. N., Howard, R., Kales, H. C., Kivimäki, M., Larson, E. B., Ogunniyi, A., … Mukadam, N. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet, 396(10248), 413–446.
Monti, J. M., Cooke, G. E., Watson, P. D., Voss, M. W., Kramer, A. F., & Cohen, N. J. (2015). Relating hippocampus to relational memory processing across domains and delays. Journal of Cognitive Neuroscience, 27(2), 234–245.
Petersen, R. C., Lopez, O., Armstrong, M. J., Getchius, T. S. D., Ganguli, M., Gloss, D., Gronseth, G. S., Marson, D., Pringsheim, T., Day, G. S., Sager, M., Stevens, J., & Rae-Grant, A. (2018). Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology, 90(3), 126.
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999). Mild cognitive impairment: Clinical characterization and outcome. Archives of Neurology, 56(3), 303–308.
Raina, P., Santaguida, P., Ismaila, A., Patterson, C., Cowan, D., Levine, M., Booker, L., & Oremus, M. (2008). Effectiveness of cholinesterase inhibitors and memantine for treating dementia: Evidence review for a clinical practice guideline. Annals of Internal Medicine, 148(5), 379–397.
Ranganath, C., & Ritchey, M. (2012). Two cortical systems for memory-guided behavior. Nature Reviews Neuroscience, 13(10), 713–726. https://doi.org/10.1038/nrn3338
Rebok, G. W., Ball, K. K., Guey, L. T., Jones, R. N., & Marsiske, M. (2014). Cognitive training and mental stimulation in older adults: A systematic review. Journal of the American Geriatrics Society, 62(1), 145–156.
Reitz, C., & Mayeux, R. (2014). Alzheimer disease: Epidemiology, diagnostic criteria, risk factors, and biomarkers. Biological Psychiatry, 76(6), 430–436.
Rentz, D. M., Amariglio, R. E., Becker, J. A., Frey, M., Olson, L. E., Frishe, K., Carmasin, J., Maye, J. E., Johnson, K. A., & Sperling, R. A. (2011). Face-name associative memory performance is related to amyloid burden in normal elderly. Neuropsychologia, 49(9). https://doi.org/10.1016/j.neuropsychologia.2011.06.006
Russ, T. C., & Morling, J. R. (2012). Cholinesterase inhibitors for mild cognitive impairment. Cochrane Database of Systematic Reviews, 2012(9). https://doi.org/10.1002/14651858.CD009132.pub2
Sanjuán, M., Navarro, E., & Calero, M. D. (2020). Effectiveness of cognitive interventions in older adults: A review. European Journal of Investigation in Health, Psychology and Education, 10(3), 876.
Selkoe, D. J. (2012). Alzheimer's disease: A central role for amyloid. The Journal of Neuropathology & Experimental Neurology, 71(5), 337-340. https://doi.org/10.1097/NEN.0b013e31824e0bb0
Sperling, R., Mormino, E., & Johnson, K. (2014). The evolution of preclinical Alzheimer’s disease: Implications for prevention trials. Neuron, 84(3), 608–622.
Downloads
Posted
Categories
License
Copyright (c) 2024 Stella Myers
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.